Commercialising biomarkers faster to improve medical treatment
On December 1, 2020 an article about our project and the project's outputs was published in the news section of the Interreg Baltice Sea Region webpage:
"A project was set into motion in 2017 with the ambitious aim to facilitate and standardize the commercialization process of new biomarkers. Biomarkers are increasingly important in disease risk prediction, diagnosis, prognosis and treatment response. The BIC project concluded in September 2020 and brought about some tools that can help medical companies to bring new biomarkers to the market faster."
Read the whole article here: https://www.interreg-baltic.eu/news-detail/news/commercialising-biomarkers-faster-to-improve-medical-treatment.html